Endra Life Sciences INC. (NDRA) — DEF 14A Filings
All DEF 14A filings from Endra Life Sciences INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
ENDRA Seeks Massive Share Authorization Hike, Officer Exculpation
— Oct 28, 2025 Risk: high
ENDRA Life Sciences Inc. (NDRA) is holding its 2025 Annual Meeting on December 9, 2025, to address several critical proposals. Key among these is a proposed ame -
ENDRA Life Sciences Files Definitive Proxy Statement
— Sep 16, 2024 Risk: low
ENDRA Life Sciences Inc. filed a definitive proxy statement (DEF 14A) on September 16, 2024, for its annual meeting. The filing details the company's governance -
ENDRA Life Sciences Files Proxy Statement for August Meeting
— Jun 25, 2024 Risk: low
ENDRA Life Sciences Inc. filed its definitive proxy statement (DEF 14A) on June 25, 2024, for its annual meeting on August 6, 2024. The filing concerns the soli
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX